Latest News about BMY
Recent news which mentions BMY
Bristol Myers Squibb (BMY) Q3 2022 Earnings Call Transcript
October 26, 2022
Tickers
BMY
From Motley Fool
Two Warren Buffett Rules You Should Never Forget
October 26, 2022
From Motley Fool
Revlimid Generic Competition, Forex Impacts Bristol Myers' Q3 Sales; Reaffirms FY22 Guidance
October 26, 2022
Tickers
BMY
From Benzinga
Nasdaq, S&P 500 Futures Lower Following Alphabet, Microsoft Earnings
October 26, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 25, 2022
From Benzinga
2 Pharma Stocks With Blockbuster Drugs on the Horizon
October 25, 2022
From Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
October 24, 2022
From Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
October 23, 2022
From Motley Fool
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
October 22, 2022
From Motley Fool
New Data Reinforce Benefits Of Bristol Myers's Opdivo In Earlier Stages Of Melanoma
October 20, 2022
Tickers
BMY
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2022
From Benzinga
Why Legend Biotech's Shares Jumped 14.2% On Tuesday
October 18, 2022
From Motley Fool
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
October 18, 2022
From InvestorPlace
Jupiter Wellness's Potential New OTC Drug Could Put Some More Joy Back Into Breast Cancer Survivors' Lives
October 18, 2022
From Benzinga
3 Fast-Growing Medical Dividend Stocks
October 17, 2022
From Motley Fool
Peering Into Bristol-Myers Squibb's Recent Short Interest
October 13, 2022
Tickers
BMY
From Benzinga
Got $5,000? These 2 Stocks Could Continue Beating the Bear Market.
October 12, 2022
From Motley Fool
The 7 Most Undervalued Value Stocks to Buy Now
October 10, 2022
From InvestorPlace
What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb
October 10, 2022
Tickers
BMY
From Benzinga
Will Chart Analysts Notice Bad Omen on Bristol-Myers Squibb's Chart
October 10, 2022
Tickers
BMY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
From Benzinga
Want to Buy the Dip? This Real Estate Stock Is a Smart Buy
October 07, 2022
From Motley Fool
PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics
October 07, 2022
From Benzinga
There are early signs that the bear market is going into hibernation
October 06, 2022
From MarketWatch
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Proprietary Off-the-Shelf Immunotherapy For Solid Tumors
October 06, 2022
From Benzinga
3 Stocks Savvy Investors Are Buying Hand Over Fist
October 06, 2022
From Motley Fool
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.